RhumbLine Advisers’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Buy |
19,541
+5,838
| +43% | +$349K | ﹤0.01% | 2166 |
|
|
2025
Q1 | $719K | Sell |
13,703
-5,549
| -29% | -$291K | ﹤0.01% | 2337 |
|
|
2024
Q4 | $1.06M | Buy |
19,252
+6,062
| +46% | +$333K | ﹤0.01% | 2226 |
|
|
2024
Q3 | $663K | Buy |
13,190
+2,221
| +20% | +$112K | ﹤0.01% | 2516 |
|
|
2024
Q2 | $482K | Buy |
10,969
+1,132
| +12% | +$49.7K | ﹤0.01% | 2702 |
|
|
2024
Q1 | $433K | Buy |
9,837
+319
| +3% | +$14K | ﹤0.01% | 2754 |
|
|
2023
Q4 | $452K | Sell |
9,518
-87
| -0.9% | -$4.13K | ﹤0.01% | 2724 |
|
|
2023
Q3 | $426K | Buy |
9,605
+385
| +4% | +$17.1K | ﹤0.01% | 2702 |
|
|
2023
Q2 | $440K | Sell |
9,220
-135
| -1% | -$6.45K | ﹤0.01% | 2776 |
|
|
2023
Q1 | $368K | Buy |
9,355
+204
| +2% | +$8.03K | ﹤0.01% | 2547 |
|
|
2022
Q4 | $259K | Buy |
9,151
+290
| +3% | +$8.21K | ﹤0.01% | 2722 |
|
|
2022
Q3 | $266K | Buy |
8,861
+572
| +7% | +$17.2K | ﹤0.01% | 2778 |
|
|
2022
Q2 | $281K | Buy |
8,289
+2,364
| +40% | +$80.1K | ﹤0.01% | 2791 |
|
|
2022
Q1 | $266K | Buy |
5,925
+747
| +14% | +$33.5K | ﹤0.01% | 2678 |
|
|
2021
Q4 | $239K | Buy |
+5,178
| New | +$239K | ﹤0.01% | 2784 |
|